1. Bains SJ, Niehusmann PF, Meling TR, Saxhaug C, Zuchner M, Brandal P. Disseminated central nervous system hemangioblastoma in a patient with no clinical or genetic evidence of von Hippel-Lindau disease-a case report and literature review. Acta Neurochir (Wien). 2019; 161:343–349. PMID:
30652202.
Article
2. Chung SY, Jeun SS, Park JH. Disseminated hemangioblastoma of the central nervous system without von Hippel-Lindau disease. Brain Tumor Res Treat. 2014; 2:96–101. PMID:
25408933.
Article
3. Kim HR, Suh YL, Kim JW, Lee JI. Disseminated hemangioblastomatosis of the central nervous system without von Hippel-Lindau disease: a case report. J Korean Med Sci. 2009; 24:755–759. PMID:
19654966.
Article
4. Amelot A, Bouazza S, Polivka M, George B, Bresson D. Sporadically second localization of cerebellar hemangioblastoma in sella turcica mimicking a meningioma with no associated von Hippel-Lindau disease. Br J Neurosurg. 2015; 29:589–591. PMID:
25817084.
Article
5. Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology. 1995; 194:629–642. PMID:
7862955.
Article
6. Girmens JF, Erginay A, Massin P, Scigalla P, Gaudric A, Richard S. Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. Am J Ophthalmol. 2003; 136:194–196. PMID:
12834696.
Article
7. Hasselblatt M, Jeibmann A, Gerss J, Behrens C, Rama B, Wassmann H, et al. Cellular and reticular variants of haemangioblastoma revisited: a clinicopathologic study of 88 cases. Neuropathol Appl Neurobiol. 2005; 31:618–622. PMID:
16281910.
Article
8. Kato M, Ohe N, Okumura A, Shinoda J, Nomura A, Shuin T, et al. Hemangioblastomatosis of the central nervous system without von Hippel-Lindau disease: a case report. J Neurooncol. 2005; 72:267–270. PMID:
15937651.
Article
9. Lee JY, Dong SM, Park WS, Yoo NJ, Kim CS, Jang JJ, et al. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res. 1998; 58:504–508. PMID:
9458097.
10. Omar AI. Bevacizumab for the treatment of surgically unresectable cervical cord hemangioblastoma: a case report. J Med Case Rep. 2012; 6:238. PMID:
22883663.
Article
11. Raghavan R, Krumerman J, Rushing EJ, White CL 3rd, Chason DP, Watson ML, et al. Recurrent (nonfamilial) hemangioblastomas involving spinal nerve roots: case report. Neurosurgery. 2000; 47:1443–1448. PMID:
11126917.
Article
12. Ramachandran R, Lee HS, Matthews B, Shatzel A, Tihan T. Intradural extramedullary leptomeningeal hemangioblastomatosis and paraneoplastic limbic encephalitis diagnosed at autopsy: an unlikely pair. Arch Pathol Lab Med. 2008; 132:104–108. PMID:
18181660.
Article
13. Takayanagi S, Mukasa A, Tanaka S, Nomura M, Omata M, Yanagisawa S, et al. Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system. Neuro Oncol. 2017; 19:1228–1236. PMID:
28379443.
Article
14. Tohyama T, Kubo O, Kusano R, Miura N, Himuro H. [A case of hemangioblastoma with subarachnoid dissemination]. No Shinkei Geka. 1990; 18:83–88. Japanese. PMID:
2304611.
15. Bakshi R, Mechtler LL, Patel MJ, Lindsay BD, Messinger S, Gibbons KJ. Spinal leptomeningeal hemangioblastomatosis in von Hippel-Lindau disease: magnetic resonance and pathological findings. J Neuroimaging. 1997; 7:242–244. PMID:
9344008.
Article
16. Mohan J, Brownell B, Oppenheimer DR. Malignant spread of haemangioblastoma: report on two cases. J Neurol Neurosurg Psychiatry. 1976; 39:515–525. PMID:
1084914.
Article
17. Reyns N, Assaker R, Louis E, Lejeune JP. Leptomeningeal hemangioblastomatosis in a case of von Hippel-Lindau disease: case report. Neurosurgery. 2003; 52:1212–1215. discussion 1215-6. PMID:
12699568.
Article
18. Weil RJ, Vortmeyer AO, Zhuang Z, Pack SD, Theodore N, Erickson RK, et al. Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases. J Neurosurg. 2002; 96:775–787. PMID:
11990821.
Article
19. Hanse MC, Vincent A, van den Bent MJ. Hemangioblastomatosis in a patient with von Hippel-Lindau disease. J Neurooncol. 2007; 82:163–164. PMID:
17256106.
Article
20. Akimoto J, Fukuhara H, Suda T, Nagai K, Hashimoto R, Michihiro K. Disseminated cerebellar hemangioblastoma in two patients without von Hippel-Lindau disease. Surg Neurol Int. 2014; 5:145. PMID:
25324974.
Article
21. Seystahl K, Weller M, Bozinov O, Reimann R, Rushing E. Neuropathological characteristics of progression after prolonged response to bevacizumab in multifocal hemangioblastoma. Oncol Res Treat. 2014; 37:209–212. PMID:
24732646.
Article
22. Kim H, Park IS, Jo KW. Meningeal supratentorial hemangioblastoma in a patient with von Hippel-Lindau disease mimicking angioblastic menigioma. J Korean Neurosurg Soc. 2013; 54:415–419. PMID:
24379949.
Article
23. Crivelli G, Dario A, Cerati M, Dorizzi A. Solid supratentorial haemangioblastoma. Case report. J Neurosurg Sci. 1992; 36:161–166. PMID:
1484303.